| Chromosome | Candidate target gene and their location | Aberration type | Reference |
|---|---|---|---|
| 1q | CSK1B(1q21.2) | Gain | [88, 89] |
| CHD1L(1q21.1) | |||
| JTB(1q21) | |||
| MDM4(1q32.1) | |||
| 1p | p18(1p32) | Loss | [90-92] |
| p73(1p36.3) | |||
| RIZ(1p36.13-p36.23) | |||
| 3q | Gankyrin (3q28) | Gain | [33] |
| 3p | ROSSF1A(3p21.3) | Loss of heterogeneity, CpG methylation | [93, 94] |
| CTNNB1(3p21) | |||
| TGF-1βR11(3q22) | |||
| 4q | Loss of heterogeneity | [95] | |
| 6p | Gain | [96] | |
| 6q | M6P/IGF2R (6q26-q27) | Loss of heterogeneity | [97] |
| 8q | c-Myc (8q24.21) | Gain | [98.99,100] |
| PTK2 (8q24.3) | |||
| EIF3S3 (8q23.3) | |||
| SGK3 (8q13.1) | |||
| 8p | DLC-1 (8p21.3-22) | Loss of heterogeneity, CpG methylation | [101] |
| LPTS (8p23) | |||
| CSMD1 (8p23.2) | |||
| 9p | CDKN2A (9p21) | Loss of heterogeneity, CpG methylation | [102] |
| CDKN2B (9q21) | |||
| 11q | cyclinD1 (11q13) | Gain | [103] |
| 10q | PTEN/MMAC1 (10q23.3) | Loss of heterogeneity | [104] |
| 11p | KAI1 (11p11.2) | Loss of heterogeneity, CpG methylation | [105] |
| IGF-2 (11p15) | |||
| TSLC1 (11p23.2) | |||
| 13q | Rb1 (13q14.2) | Loss of heterogeneity | [106, 107] |
| BRCA2 (13q12.3) | |||
| Tg737 (13q12.1) | |||
| TFDP1 (13q34) | |||
| CUL4A (13q34) | |||
| CDC1 (13q34) | |||
| 16q | CDH1 (16q22.1) | Loss of heterogeneity, CpG methylation | [102] |
| 16p | Axin1 (16p13.3) | CpG methylation | [108] |
| SOCS-1 (16p13.3) | |||
| 17p | p53 (17p13.1) | Loss of heterogeneity | [103, 109] |
| HIC-1 (17p13.3) | |||
| HCCS1 (17p13.3) |